Continuing Medical Education Participant Evaluation Form
Thank you for attending this CME/CE activity. Your feedback is essential to improve the quality and effectiveness of our educational programs. Please complete this form honestly.
*
Full Name
*
Mobile No.
*
Job Title
*
Company
*
Email Address for CME Certificate
*
Section 1: Activity Content
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
1. The learning objectives were clearly stated.
2. The content was relevant to my professional practice.
3. The activity was evidence-based and free from commercial bias.
Section 2: Educational Effectiveness
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
4. The activity increased my knowledge on the topic.
5. The activity will change or reinforce my practice.
6. The teaching methods were effective (e.g., lectures, case discussions, workshops).
Section 3: Speaker/Faculty Evaluation
*
7. The speaker(s) were knowledgeable and well-prepared.
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
From Clinical Insights to Clinical Impact: Dupilumab in CSU - Dr. Ahmed Ameen
Elevating CSU Care with Dupilumab: Evidence to Efficacy - Dr. Zaidoon Abdelhadi
8. The speaker(s) presented information in a clear and understandable manner
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
From Clinical Insights to Clinical Impact: Dupilumab in CSU - Dr. Ahmed Ameen
Elevating CSU Care with Dupilumab: Evidence to Efficacy - Dr. Zaidoon Abdelhadi
Section 4: Overall Experience
*
Excellent
Good
Fair
Poor
9. The overall quality of the activity met my expectations.
10. The activity met my professional needs.
11. The activity has impact on improving patient care
*
Yes
No
12. The program was well organized.
13. Would you recommend this activity to your colleagues?
14. Should this program be offered again?
If yes, how often?
Annually
Biannually
Other
Section 5: Open-Ended Feedback
*
15. What was the most valuable part of this activity?
*
16. How could this activity be improved?
*
17. What topics would you like to have in the future?
*
18. Additional comments or suggestions:
